Use of Spironolactone in SARS-CoV-2 ARDS Patients
Yıl: 2020 Cilt: 48 Sayı: 3 Sayfa Aralığı: 254 - 255 Metin Dili: İngilizce DOI: 10.5152/TJAR.2020.569 İndeks Tarihi: 12-05-2021
Use of Spironolactone in SARS-CoV-2 ARDS Patients
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 1-4. [Crossref]
- 2. Busse LW, Wang XS, Chalikonda DM, Finkel KW, Khanna AK, Szerlip HM, et al. Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety. Read Online Crit Care Med Soc Crit Care Med 2017; 45: 1285-94. [Crossref]
- 3. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive Care Med 2020; 1-4. [Crossref]
- 4. Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 2020; DOI: 10.1016/j.jinf.2020.03.062. [Crossref]
- 5. Busse LW, Chow JH, McCurdy MT, Khanna AK. COVID-19 and the RAAS-a potential role for angiotensin II? Crit Care 2020; 24: 136. [Crossref]
- 6. Cadegiani FA. Can spironolactone be used to prevent COVID19-induced acute respiratory distress syndrome in patients with hypertension? Am J Physiol-Endocrinol Metab 2020; 318: E587-8. [Crossref]
- 7. Barrera-Chimal J, Rocha L, Amador-Martínez I, Pérez-Villalva R, González R, Cortés-González C, et al. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation. Nephrol Dial Transplant 2019; 34: 794-801. [Crossref]
- 8. Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, et al. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial. JAMA Cardiol 2017; 2: 950-8. [Crossref]
- 9. Desai AS, Liu J, Pfeffer MA, Claggett B, Fleg J, Lewis EF, et al. Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial. J Card Fail 2018; 24: 313-20. [Crossref]
| APA | Yartaş Dumanlı G, Dilken O, Urkmez S (2020). Use of Spironolactone in SARS-CoV-2 ARDS Patients. , 254 - 255. 10.5152/TJAR.2020.569 |
| Chicago | Yartaş Dumanlı Güleren,Dilken Olcay,Urkmez Seval Use of Spironolactone in SARS-CoV-2 ARDS Patients. (2020): 254 - 255. 10.5152/TJAR.2020.569 |
| MLA | Yartaş Dumanlı Güleren,Dilken Olcay,Urkmez Seval Use of Spironolactone in SARS-CoV-2 ARDS Patients. , 2020, ss.254 - 255. 10.5152/TJAR.2020.569 |
| AMA | Yartaş Dumanlı G,Dilken O,Urkmez S Use of Spironolactone in SARS-CoV-2 ARDS Patients. . 2020; 254 - 255. 10.5152/TJAR.2020.569 |
| Vancouver | Yartaş Dumanlı G,Dilken O,Urkmez S Use of Spironolactone in SARS-CoV-2 ARDS Patients. . 2020; 254 - 255. 10.5152/TJAR.2020.569 |
| IEEE | Yartaş Dumanlı G,Dilken O,Urkmez S "Use of Spironolactone in SARS-CoV-2 ARDS Patients." , ss.254 - 255, 2020. 10.5152/TJAR.2020.569 |
| ISNAD | Yartaş Dumanlı, Güleren vd. "Use of Spironolactone in SARS-CoV-2 ARDS Patients". (2020), 254-255. https://doi.org/10.5152/TJAR.2020.569 |
| APA | Yartaş Dumanlı G, Dilken O, Urkmez S (2020). Use of Spironolactone in SARS-CoV-2 ARDS Patients. Turkish Journal of Anaesthesiology and Reanimation, 48(3), 254 - 255. 10.5152/TJAR.2020.569 |
| Chicago | Yartaş Dumanlı Güleren,Dilken Olcay,Urkmez Seval Use of Spironolactone in SARS-CoV-2 ARDS Patients. Turkish Journal of Anaesthesiology and Reanimation 48, no.3 (2020): 254 - 255. 10.5152/TJAR.2020.569 |
| MLA | Yartaş Dumanlı Güleren,Dilken Olcay,Urkmez Seval Use of Spironolactone in SARS-CoV-2 ARDS Patients. Turkish Journal of Anaesthesiology and Reanimation, vol.48, no.3, 2020, ss.254 - 255. 10.5152/TJAR.2020.569 |
| AMA | Yartaş Dumanlı G,Dilken O,Urkmez S Use of Spironolactone in SARS-CoV-2 ARDS Patients. Turkish Journal of Anaesthesiology and Reanimation. 2020; 48(3): 254 - 255. 10.5152/TJAR.2020.569 |
| Vancouver | Yartaş Dumanlı G,Dilken O,Urkmez S Use of Spironolactone in SARS-CoV-2 ARDS Patients. Turkish Journal of Anaesthesiology and Reanimation. 2020; 48(3): 254 - 255. 10.5152/TJAR.2020.569 |
| IEEE | Yartaş Dumanlı G,Dilken O,Urkmez S "Use of Spironolactone in SARS-CoV-2 ARDS Patients." Turkish Journal of Anaesthesiology and Reanimation, 48, ss.254 - 255, 2020. 10.5152/TJAR.2020.569 |
| ISNAD | Yartaş Dumanlı, Güleren vd. "Use of Spironolactone in SARS-CoV-2 ARDS Patients". Turkish Journal of Anaesthesiology and Reanimation 48/3 (2020), 254-255. https://doi.org/10.5152/TJAR.2020.569 |
